Longidaza Lyophilisate for Injection 3000 IU (Bovhyaluronidase Azoximer) – Anti-Fibrotic & Enzyme Therapy, 5 Vials

Longidaza Lyophilisate for Injection 3000 IU (Bovhyaluronidase Azoximer) – Anti-Fibrotic & Enzyme Therapy, 5 Vials

Description:

Longidaza is a lyophilisate for injection containing bovhyaluronidase azoximer, an enzyme conjugate with anti-fibrotic and anti-inflammatory properties. It is used in complex therapy to reduce fibrosis, adhesions, and connective tissue overgrowth.

Key Benefits:

• Anti-fibrotic properties: helps reduce fibrosis in various tissues.
• Anti-inflammatory effect: contributes to reducing inflammation.
• Improved tissue permeability: enhances the permeability of tissues, facilitating the penetration of therapeutic agents.
• Support for tissue repair: promotes the regeneration of tissues.

Applications:

Longidaza is suitable for use in the following areas:

• Gynecology: as part of complex therapy for various gynecological conditions.
• Dermatology: for the treatment of skin diseases associated with fibrosis and inflammation.
• Genitourinary system: in the treatment of diseases of the genitourinary system.
• Musculoskeletal system: to reduce fibrosis and improve tissue permeability in musculoskeletal disorders.

Product Details:

• Form: lyophilisate for injection.
• Content: 3000 IU per vial.
• Quantity: 5 vials in a package.

Longidaza is a reliable solution for addressing fibrosis and connective tissue disorders in various fields of medicine. Consult your healthcare provider for more information and to determine if Longidaza is appropriate for your treatment plan.